Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis - Double blind placebo controlled study

Inflammation Research

Volumn 50, Issue 12, 2001, Pages 598-601

  Valleala, H ^a   Laitinen, K ^a   Pylkkanen L ^b   Konttinen, Y T ^c   Friman, C ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Oy Leiras Finland Ab   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Clodronate; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CLODRONIC ACID; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0035664888     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000240     Document Type: Article

References (22)

1. Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management
2. Bone metabolism in rheumatoid arthritis; relation to disease activity
3. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease
4. Effects of clodronate on vertebral fracture risk in osteoporosis: A 1-year interim analysis
5. Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate
6. Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis
7. A comparison of clodronate and indomethacin in the treatment of adjuvant arthritis
8. Effect of clodronate on established collagen-induced arthritis in rats
9. Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis
10. Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: A double blind placebo controlled study
11. An open study of pamidronate in the treatment of refractory ankylosing spondylitis
12. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate
13. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
14. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?
15. Phagocytic synovial lining cells regulate acute and chronic joint inflammation after antigenic exacerbation of smouldering experimental murine arthritis
16. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
17. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alphamonoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
18. Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro
19. Macrophage depletion by albumin microencapsulated clodronate: Attenuation of cytokine release in macrophage-dependent glomerulonephritis
20. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis
21. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis
22. Depletion of synovium of patients with rheumatoid arthritis